Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

FormBlends vs NextMeds

FormBlends
Graded #78

Higher grade

vs+6.300000000000011
NextMeds
Graded #207

Lower grade

The verdict

FormBlends takes it — 72.4/100 to 66.1/100.

FormBlends grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FormBlends is a US direct-to-consumer brand selling compounded GLP-1 weight-loss medication — compounded semaglutide from $99 and compounded tirzepatide from $349 — dispensed by a licensed 503A pharmacy and…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFormBlends +28
83
55
Dose & formulationFormBlends +13
77
64
Clinical oversightNextMeds +1
76
77
Labs & monitoringNextMeds +9
52
61
FulfillmentNextMeds +10
74
84
Contract termsNextMeds +6
55
61
FormBlends · left barNextMeds · right bar

The numbers

MetricFormBlendsNextMeds
WeighScore72.4/10066.1/100
GradeCC
Scorecard rank#78#207
Semaglutide$99/mo (compounded)$129/mo (plus a separate fee, compounded)
Tirzepatide$349/mo (compounded)$179/mo (plus a separate fee, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
FormBlends

Graded #78 · C

Strengths

  • Low published entry price on compounded semaglutide ($99) from a licensed 503A pharmacy
  • Physician-supervised program with 24/7 care-team access and free shipping over $150
  • Extensive free educational content, guides and provider comparisons on-site

Where it loses points

  • Enrollment and final pricing complete on an external portal (rx.formscripts.com), not fully on-site
  • $99 may be an intro rate; tirzepatide is comparatively high at $349/mo
  • State availability and LegitScript status not published; pharmacy is its own FormScripts brand
NextMeds

Graded #207 · C

Strengths

  • Flat monthly membership bundles the medication, telehealth visits, a 1:1 care coach and a licensed registered dietitian — one price, no hidden fees
  • Same price every dose, no auto-renewal, cancel anytime; free shipping and no insurance needed (FSA eligible)
  • Names a compounding pharmacy partner (Foothills Pharmacy) and states it services all 50 states
  • Free, no-obligation online assessment before you pay anything

Where it loses points

  • Shows a LegitScript 'approval' but links only a generic directory search, not a verifiable seal — we couldn't independently confirm it
  • Promo-driven pricing with a countdown timer and 'price increases' urgency; the standing membership is $129 (sema) / $179 (tirz)
  • A technology platform that coordinates care, not the medical provider; individual clinicians and a medical director aren't named on the site
  • Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
  • Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard